Fanny Ledys
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet.
Journal: The Journal of clinical investigation
Published: July 05, 2024
Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era.
Journal: Cells
Published: January 17, 2022
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Journal: British journal of cancer
Published: June 26, 2019
Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.
Journal: Advances in therapy
Published: February 04, 2019
RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer.
Journal: Journal for immunotherapy of cancer
Published: August 01, 2018
Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 18, 2018
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Journal: British journal of cancer
Published: February 28, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026